Evidence map›Paper›PMID 36232419›Full record

ArticleInternational journal of molecular sciences2022

Surfactin Mitigates a High-Fat Diet and Streptozotocin-Induced Type 2 Diabetes through Improving Pancreatic Dysfunction and Inhibiting Inflammatory Response.

Xiaoyu Chen, Hongyuan Zhao, Yajun Lu, Huawei Liu, Fanqiang Meng, Zhaoxin Lu, Yingjian Lu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Study of the Hypoglycemic Activity of Rhamnolipids Using theCurrent issues in molecular biology · 2026
    Article
  3. Immunomodulatory Properties of the Cyclic Lipopeptide Surfactin.Journal of microbiology and biotechnology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xiaoyu ChenCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Hongyuan ZhaoCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Yajun LuCollege of Chemistry and Chemical, Nanjing Tech University, Nanjing 211816, China.
Huawei LiuCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0001-6256-3202
Fanqiang MengCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0001-6330-4536
Zhaoxin LuCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.ORCID 0000-0001-9288-7419
Yingjian LuCollege of Food Science and Engineering, Nanjing University of Finance and Economics, Nanjing 210023, China.
Nanjing Agricultural University · CNNanjing Tech University · CN

Funding

the National Natural Science Foundation of China (No.32072182
6 · The paper itself

Abstract

Surfactin from

Indexed as

Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Insulin ResistanceAnimalsBlood GlucoseClaudin-1Diet, High-FatGlucagonGlucoseInflammationMiceOccludinPancreasPancreatic HormonesPhosphatidylinositol 3-KinasesPhosphatidylinositolsBlood GlucoseClaudin-1GlucagonGlucoseOccludinPancreatic HormonesPhosphatidylinositol 3-KinasesPhosphatidylinositolsProto-Oncogene Proteins c-aktStreptozocingut-barrierinflammationpancreassurfactin

Identifiers

PMID36232419
PMCPMC9570334
OpenAlexW4296626626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.